Cream, Ointment

Glaxo Smithkline

Eumovate (clobetasol 17 butyrate) is used for the treatment of milder forms of eczema, seborrheic dermatitis, and other similar skin conditions.

Do not take Eumovate (clobetasol 17 butyrate) if you are allergic to any ingredient in Eumovate (clobetasol 17 butyrate) if you have a simultaneous bacterial, viral or fungal infection.

Before using Eumovate (clobetasol 17 butyrate), tell your health care provider about any of the following: if you are pregnant, planning to become pregnant, or breastfeeding if you are taking any other prescription medicine, nonprescription medicine, herbal preparation, or dietary supplement if you have impaired kidney or liver function, if you have heart or lung problem stasis dermatitis and other skin diseases associated with impaired circulation if you have a bacterial, viral or fungal infection

Eumovate (clobetasol 17 butyrate) is for external use only. Prolonged or extensive use of topical corticosteriod products may produce atrophy of the skin and s.c. tissue, particularly on flexor surfaces and on the face. If this is noted, the use of the drug should be discontinued. This product should not be used in the eye and should be used with caution in lesions close to the eye as glaucoma may result.

Other: Transient adrenal suppression, glaucoma, cataract.

How much medicine you use and how often you use it depends on many factors, including the condition being treated and the age and weight of the patient. If you have any questions about the amount and/or frequency of Eumovate (clobetasol 17 butyrate) you are using, talk with your health care provider. Do not stop using Eumovate (clobetasol 17 butyrate) or change the dose without checking with your health care provider. This could have serious adverse effects. When used under occlusive dressing, over extensive areas for prolonged periods, it is possible that sufficient absorption may take place to give rise to transient adrenal suppression. Long-term continuous topical corticosteroid therapy should be avoided where possible as adrenal suppression can occur even without occlusion. Inform your health care provider about the previous use of corticosteroids. Significant systemic absorption may result when corticosteroids are applied over large areas of the body. To minimize this possibility, treatment should be interrupted periodically or one area of the body should be treated at a time when long-term therapy is anticipated. In infants, the diaper may act as an occlusive dressing and increase absorption. Prolonged application of Eumovate (clobetasol 17 butyrate) to the face is not recommended. Patients with previous medical conditions should talk with their health care provider before taking Eumovate (clobetasol 17 butyrate). Do not take any other over-the-counter or prescription medications without talking with your health care provider. If a dose is missed, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. If more than one dose is missed, contact your health care provider or pharmacist.

Store Eumovate (clobetasol 17 butyrate) at room temperature in a cool, dry place. Protect from direct heat and light. Kep out of the reach of children and pets